Botanix Pharmaceuticals Limited has released a press release.
Botanix Quarterly Activities Report and Appendix 4C Q4 FY26
Earlier from Botanix Pharmaceuticals
- Notice of Allowance for US patent on Sofdra drug substance
- Intention to Grant a European patent on Sofdra applicator
- Botanix Quarterly Activities Report and Appendix 4C Q3 FY26
- Botanix reaches term sheet agreement with 2nd API supplier